High ICSMA-20-196-01 1 CVE

Capsule Technologies SmartLinx Neuron 2 (Update A)

Published Jul 14, 2020 · Updated Oct 20, 2020 · Revision 2

Vendor: Capsule Technologies Product: SmartLinx Neuron 2

Summary

Successful exploitation of this vulnerability could provide an attacker with full control of a trusted device on a hospital 's internal network.

Vulnerabilities 1

High 7.6

CVE-2019-5024

A restricted environment escape vulnerability exists in the “kiosk mode” function of Capsule Technologies SmartLinx Neu…

Capsule Technologies Capsule Technologies SmartLinx Neuron 2

Apr 11, 2019

Revision history

2020-10-20 #2
ICSMA-20-196-01 Capsule Technologies SmartLinx Neuron 2 (Update A)
2020-07-14 #1
ICSMA-20-196-01 Capsule Technologies SmartLinx Neuron 2

References

ICS Advisory ICSMA-20-196-01 Web Version
https://www.cisa.gov/news-events/ics-medical-advisories/icsma-20-196-01
Recommended Practices
https://www.us-cert.gov/sites/default/files/recommended_practices/NCCIC_ICS-CERT_Defense_in_Depth_2016_S508C.pdf
Recommended Practices
https://www.us-cert.gov/ics/tips/ICS-TIP-12-146-01B